Advertisement

Binding Properties of DNA and Antimicrobial Peptide Chensinin-1b Containing Lipophilic Alkyl Tails

  • Weibing Dong
  • Xueyue Luo
  • Yue Sun
  • Yue Li
  • Cui Wang
  • Yue Guan
  • Dejing ShangEmail author
ORIGINAL ARTICLE

Abstract

Multidrug-resistant bacteria present an important threat to human health. In this study, due to the weak antimicrobial activity of chensinin-1b against multidrug-resistant (MDR) bacteria, three lipo-chensinin-1b peptides, including OA-C1b, LA-C1b and PA-C1b, were designed and their activities against MDR bacteria were examined. Both the OA-C1b and LA-C1b peptides exhibited potent antimicrobial activity against selected multidrug-resistant bacterial strains. In addition to the direct disruption of bacterial membranes by antimicrobial peptides, it has also been proposed that DNA is a superior intracellular target for antimicrobial peptides. ctDNA was used as a model to investigate the binding properties of DNA and lipo-chensinin-1b peptides using a variety of biophysical methods. The kinetics results of both UV-Vis and CD spectroscopy suggested that the interaction between lipo-chensinin-1b peptides and ctDNA was concentration-dependent and resulted in an increase in polynucleotide helicity. Viscosity measurements, Trp fluorescence and iodide quenching experiments indicated that nonclassical groove binding and electrostatic binding interaction modes were utilized when the peptides interacted with the ctDNA. In addition, the formation of peptide-ctDNA complexes was monitored using dynamic light scattering experiments, during which the peptide exhibited the ability to neutralize the negative charges on the surface of the ctDNA. These results promote the possibility of designing peptide-based antibiotics targeted to DNA.

Keywords

Antimicrobial peptide DNA Binding interaction Aliphatic acid Multidrug-resistant bacteria 

Notes

Acknowledgements

This study was supported by the National Natural Science Foundation of China (31872225, 21502083 and 31672289), China Postdoctoral Science Foundation (2016 M601330), LiaoNing Revitalization Talents Program (XLYC1807251) and the funding from Dalian Science and Technology Bureau (2017RQ142).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

10895_2019_2478_MOESM1_ESM.pdf (403 kb)
ESM 1 (PDF 403 kb)

References

  1. 1.
    Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775–781PubMedCrossRefGoogle Scholar
  2. 2.
    Levy SB (1998) Multidrug resistance--a sign of the times. N Engl J Med 338:1376–1378PubMedCrossRefGoogle Scholar
  3. 3.
    Lewis K (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12:371–387PubMedCrossRefGoogle Scholar
  4. 4.
    Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395PubMedCrossRefGoogle Scholar
  5. 5.
    Yang L, Harroun TA, Weiss TM, Ding L, Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J81:1475–1485Google Scholar
  6. 6.
    Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y (1992) Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31:12416–12423PubMedCrossRefGoogle Scholar
  7. 7.
    Matsuzaki K, Murase O, Fujii N, Miyajima K (1996) An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35:11361–11368PubMedCrossRefGoogle Scholar
  8. 8.
    Ding L, Yang L, Weiss TM, Waring AJ, Lehrer RI, Huang HW (2003) Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 42:12251–12259PubMedCrossRefGoogle Scholar
  9. 9.
    Li Y, Qi X, Zhang Q, Huang Y, Su Z (2012) Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 37:207–215PubMedCrossRefGoogle Scholar
  10. 10.
    Sun Y, Dong W, Sun L, Ma L, Shang D (2015) Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b. Biomaterials 37:299–311PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Park CB, Kim HS, Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244:253–257PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Boman HG, Agerberth B, Boman A (1993) Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61:2978–2984PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Gupta RC, Spencer-Beach G (1996) Natural and endogenous DNA adducts as detected by 32P-postlabeling. Regul Toxicol Pharmacol 23:14–21PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Tennant AH, Peng B, Kligerman AD (2001) Genotoxicity studies of three triazine herbicides: in vivo studies using the alkaline single cell gel (SCG) assay. Mutat Res 493:1–10PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Boer DR, Canals A, Coll M (2009) DNA-binding drugs caught in action: the latest 3D pictures of drug-DNA complexes. Dalton Trans:399–414Google Scholar
  16. 16.
    Pindur U, Jansen M, Lemster T (2005) Advances in DNA-ligands with groove binding, intercalating and/or alkylating activity: chemistry, DNA-binding and biology. Curr Med Chem 12:2805–2847PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Upadhyay SK (2017) Binding and thermodynamics of REV peptide-ctDNA interaction. Biopolymers 108:e22902CrossRefGoogle Scholar
  18. 18.
    Mukherjee A, Mondal S, Singh B (2017) Spectroscopic, electrochemical and molecular docking study of the binding interaction of a small molecule 5H-naptho[2,1-f][1,2] oxathieaphine 2,2-dioxide with calf thymus DNA. Int J Biol Macromol 101:527–535PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Zhang G, Zhang Y, Zhang Y, Li Y (2013) Spectroscopic studies of cyanazine binding to calf thymus DNA with the use of ethidium bromide as a probe. Sensor Actuat B-Chem 182:453–460CrossRefGoogle Scholar
  20. 20.
    Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D (2018) Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails. Eur J Med Chem 150:546–558PubMedCrossRefGoogle Scholar
  21. 21.
    Pal T, Abraham B, Sonnevend A, Jumaa P, Conlon JM (2006) Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties. Int J Antimicrob Agents 27:525–529PubMedCrossRefGoogle Scholar
  22. 22.
    Park NG, Lee S, Oishi O, Aoyagi H, Iwanaga S, Yamashita S, Ohno M (1992) Conformation of tachyplesin I from tachypleus tridentatus when interacting with lipid matrices. Biochemistry 31:12241–12247PubMedCrossRefGoogle Scholar
  23. 23.
    Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, Clements D, Tang H, Scott RW, Tew GN, Diamond G (2007) Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 51:4125–4132PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Dong W, Mao X, Guan Y, Kang Y, Shang D (2017) Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues. Sci Rep 7:40228PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    van der Wal A, Minor M, Norde W, Zehnder AJB, Lyklema J (1997) Electrokinetic potential of bacterial cells. Langmuir 13:165–171CrossRefGoogle Scholar
  26. 26.
    Shang D, Meng X, Zhang D, Kou Z (2017) Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa. Biochem Pharmacol 143:65–78PubMedCrossRefGoogle Scholar
  27. 27.
    Pathak N, Salas-Auvert R, Ruche G, Janna MH, McCarthy D, Harrison RG (1995) Comparison of the effects of hydrophobicity, amphiphilicity, and alpha-helicity on the activities of antimicrobial peptides. Proteins. 22:182–186PubMedCrossRefGoogle Scholar
  28. 28.
    Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250PubMedCrossRefGoogle Scholar
  29. 29.
    Kawasaki H, Koyama T, Conlon JM, Yamakura F, Iwamuro S (2008) Antimicrobial action of histone H2B in Escherichia coli: evidence for membrane translocation and DNA-binding of a histone H2B fragment after proteolytic cleavage by outer membrane proteinase T. Biochimie 90:1693–1702PubMedCrossRefGoogle Scholar
  30. 30.
    Subastri A, Ramamurthy CH, Suyavaran A, Mareeswaran R, Lokeswara Rao P, Harikrishna M, Suresh Kumar M, Sujatha V, Thirunavukkarasu C (2015) Spectroscopic and molecular docking studies on the interaction of troxerutin with DNA. Int J Biol Macromol 78:122–129PubMedCrossRefGoogle Scholar
  31. 31.
    Shahabadi N, Maghsudi M (2014) Multi-spectroscopic and molecular modeling studies on the interaction of antihypertensive drug; methyldopa with calf thymus DNA. Mol BioSyst 10:338–347PubMedCrossRefGoogle Scholar
  32. 32.
    Fu XB, Liu DD, Lin Y, Hu W, Mao ZW, Le XY (2014) Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions. Dalton Trans:8721–8737PubMedCrossRefGoogle Scholar
  33. 33.
    Sirajuddin M, Ali S, Badshah A (2013) Drug–DNA interactions and their study by UV–visible, fluorescence spectroscopies and cyclic voltametry. J Photochem Photobiol B 124:1–19PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Dong W, Sun Y, Shang D (2015) Interactions between chensinin-1, a natural antimicrobial peptide derived from Rana chensinensis, and lipopolysaccharide. Biopolymers 103:719–726PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Erkkila KE, Odom DT, Barton JK (1999) Recognition and reaction of metallointercalators with DNA. Chem Rev 99:2777–2799PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Mati SS, Roy SS, Chall S, Bhattacharya S, Bhattacharya SC (2013) Unveiling the groove binding mechanism of a biocompatible naphthalimide-based organoselenocyanate with calf thymus DNA: an “ex vivo” fluorescence imaging application appended by biophysical experiments and molecular docking simulations. J Phys Chem B 117:14655–14665PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Ranjbar B, Gill P (2009) Circular dichroism techniques: biomolecular and nanostructural analyses- a review. Chem Biol Drug Des 74:101–120PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Bhattacharya S, Mandal SS (1997) Interaction of surfactants with DNA. Role of hydrophobicity and surface charge on intercalation and DNA melting. Biochim Biophys Acta 1323:29–44PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Zhou X, Zhang G, Wang L (2014) Probing the binding mode of psoralen to calf thymus DNA. Int J Biol Macromol 67:228–237PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Macías B, Villa MV, Lapresa R, Alzuet G, Hernández-Gil J, Sanz F (2012) Mn(II) complexes with sulfonamides as ligands. DNA interaction studies and nuclease activity. J Inorg Biochem 115:64–71PubMedCrossRefGoogle Scholar
  41. 41.
    Shah A, Zaheer M, Qureshi R, Akhter Z, Nazar MF (2010) Voltammetric and spectroscopic investigations of 4-nitrophenylferrocene interacting with DNA. Spectrochim Acta A Mol Biomol Spectrosc 75:1082–1087PubMedCrossRefGoogle Scholar
  42. 42.
    Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D (2016) Structure-activity analysis and biological studies of chensinin-1b analogues. Acta Biomater 37:59–68PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.School of Life ScienceLiaoning Normal UniversityDalianChina
  2. 2.Liaoning Provincial Key Laboratory of Biotechnology and Drug DiscoveryLiaoning Normal UniversityDalianChina
  3. 3.Department of NeurologyDalian Municipal Central HospitalDalianChina

Personalised recommendations